Intellia Therapeutics, Inc. NTLA
9.70 USD -0.85 (-8.06%)
At closeNov 13, 2026, 7:57 PM EST
9.80 +0.10 +1.03%
After hours · Nov 13, 7:57 PM ET
9.67 Day range 10.50
8.04 52-week range 17.84
- YTD
- +7.90%
- 1 year
- +11.88%
NTLA revenue history
Revenue is income from the company’s ordinary business activities.
67,671,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 67,671,000 | 9,794,000 | 16.92% |
| FY 2024 | 2024-12-31 | 57,877,000 | 21,602,000 | 59.55% |
| FY 2023 | 2023-12-31 | 36,275,000 | -15,846,000 | -30.40% |
| FY 2022 | 2022-12-31 | 52,121,000 | 19,068,000 | 57.69% |
| FY 2021 | 2021-12-31 | 33,053,000 | -24,941,000 | -43.01% |
| FY 2020 | 2020-12-31 | 57,994,000 | 14,891,000 | 34.55% |
| FY 2019 | 2019-12-31 | 43,103,000 | 12,669,000 | 41.63% |
| FY 2018 | 2018-12-31 | 30,434,000 | 4,317,000 | 16.53% |
| FY 2017 | 2017-12-31 | 26,117,000 | 9,638,000 | 58.49% |
| FY 2016 | 2016-12-31 | 16,479,000 | 10,435,000 | 172.65% |
| FY 2015 | 2015-12-31 | 6,044,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:55.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.